Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
83 studies found for:    "factor V Leiden thrombophilia" OR "Thrombophilia"
Show Display Options
Rank Status Study
21 Unknown  Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®)
Condition: Cancer
Intervention:
22 Completed Does Vitamin D Deficiency Associated With Hypercoagulability & Increased Thrombin Generation?
Condition: Chest Pain
Intervention:
23 Completed Biomarker Sub Study of the Compression Stockings to Prevent the Post-Thrombotic Syndrome (SOX) Trial
Condition: Deep Venous Thrombosis
Intervention:
24 Terminated Fetal Loss in Women With Unprovoked Thromboembolism (FLUTE)
Conditions: Venous Thromboembolism;   Fetal Death
Intervention: Other: Thrombophilia Testing
25 Completed Bovine Lactoferrin to Prevent and Cure Iron Deficiency and Iron Deficiency Anemia in Complicated Pregnancies
Conditions: Pregnancy;   Iron Deficiency;   Iron Deficiency Anemia
Interventions: Dietary Supplement: Lattoglobina (Grunenthal) containing bLf;   Drug: FerroGrad by Abbott
26 Completed Evaluating the Relationship Between Blood Clotting Disorders, Inflammation, and Obesity in Individuals With Venous Disorders and Post-Thrombotic Syndrome
Conditions: Venous Thrombosis;   Venous Insufficiency
Intervention:
27 Completed Determination of Performance Characteristics of the MassPLEX Factor II/V Leiden Test
Conditions: Factor V Leiden;   Factor II;   Thrombosis
Intervention:
28 Recruiting Low Weight Heparin prOphylaxis for Placental‐Mediated Complications of PrEgnancy
Conditions: High Risk Pregnant Women;   Placental Insufficiency;   Preeclampsia
Intervention: Drug: Enoxaparin
29 Completed Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery
Conditions: Thromboembolism;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Other: coagulation study;   Other: immunoenzyme technique;   Other: laboratory biomarker analysis;   Other: physiologic testing;   Procedure: study of high risk factors
30 Not yet recruiting Atenativ Effect on Uterine Blood Flow and Preeclampsia
Condition: Antithrombin III Deficiency
Intervention: Drug: Atenativ
31 Terminated
Has Results
Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP)
Condition: Thrombotic Thrombocytopenic Purpura
Interventions: Drug: Rituximab;   Procedure: Plasma exchange;   Drug: Corticosteroids
32 Unknown  4G/5G Polymorphism of Plasminogen Activator Inhibitor-1 Gene and Disseminated Intravascular Coagulation in Severe Sepsis and Septic Shock
Condition: Severe Sepsis
Intervention:
33 Completed Efficacy and Safety Study of Protein C Concentrate in Subjects With Severe Congenital Protein C Deficiency
Condition: Protein C Deficiency
Intervention: Drug: Protein C Concentrate (Human) Vapor Heated
34 Unknown  The Use of Rituximab in Acute Thrombotic Thrombocytopenic Purpura (TTP)
Condition: Thrombotic Thrombocytopenic Purpura (TTP)
Intervention: Drug: Rituximab
35 Recruiting Safety, Pharmacokinetics and Efficacy of an AT-III Concentrate.
Condition: Antithrombin III Deficiency
Intervention: Drug: Plasma-derived AT-III concentrate
36 Completed Rituximab in Adult Acquired Idiopathic Thrombotic Thrombocytopenic Purpura
Condition: Thrombotic Thrombocytopenic Purpura
Intervention: Drug: rituximab
37 Completed Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation
Conditions: Sepsis;   Disseminated Intravascular Coagulation
Interventions: Drug: ART-123;   Drug: placebo
38 Completed An Open-label Study of KW-3357
Condition: Disseminated Intravascular Coagulation (DIC)
Interventions: Drug: KW-3357;   Drug: Plasma-derived antithrombin
39 Withdrawn The Plasma Large-Volume Exchange RCT
Conditions: Purpura, Thrombotic Thrombocytopenic;   Hemolytic Uremic Syndrome
Intervention: Procedure: Plasma Exchange
40 Terminated A Phase 3 Clinical Study of KW-3357 in Patients With DIC
Condition: Disseminated Intravascular Coagulation (DIC)
Intervention: Drug: KW-3357

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years